Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. J Neurooncol. 2016 12; 130(3):571-579.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Benzazepines
Bevacizumab
Brain Neoplasms
Female
Glioma
Humans
Male
Middle Aged
Time Factors
authors with profiles
Deric Park